Global Human Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2020-12-28
- Report ID: 35492
- Pages: 119
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Market's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Human Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Human Vaccines Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Human Vaccines Market
AstraZeneca plc
Bavarian Nordic
Bharat Biotech
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co, Inc.
Mymetics
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Shenzhen Kangtai Biological Products Co., Ltd.
Takeda Pharmaceutical Company Limited
...
Major Type of Human Vaccines Covered in Prudent Markets report:
Conjugate
Recombinant
Inactivated
Combination
Attenuated
Others
Application Segments Covered in Prudent Markets Market
Pediatrics
Adolescents
Adults
Geriatrics
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Human Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Conjugate -Product Introduction and Major Manufacturers
1.1.2 Recombinant -Product Introduction and Major Manufacturers
1.1.3 Inactivated -Product Introduction and Major Manufacturers
1.1.4 Combination -Product Introduction and Major Manufacturers
1.1.5 Attenuated -Product Introduction and Major Manufacturers
1.1.6 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Human Vaccines Status and Prospect (2015-2026)
2.1.1 China Human Vaccines Market Size and Growth Rate (2015-2026)
2.1.2 China Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Human Vaccines Status and Prospect (2015-2026)
2.2.1 EU Human Vaccines Market Size and Growth Rate (2015-2026)
2.2.2 EU Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Human Vaccines Status and Prospect (2015-2026)
2.3.1 USA Human Vaccines Market Size and Growth Rate (2015-2026)
2.3.2 USA Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Human Vaccines Status and Prospect (2015-2026)
2.4.1 Japan Human Vaccines Market Size and Growth Rate (2015-2026)
2.4.2 Japan Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Human Vaccines Status and Prospect (2015-2026)
2.5.1 India Human Vaccines Market Size and Growth Rate (2015-2026)
2.5.2 India Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Human Vaccines Status and Prospect (2015-2026)
2.6.1 Southeast Asia Human Vaccines Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Human Vaccines Status and Prospect (2015-2026)
2.7.1 South America Human Vaccines Market Size and Growth Rate (2015-2026)
2.7.2 South America Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Human Vaccines Status and Prospect (2015-2026)
2.8.1 Human Vaccines Market Size and Growth Rate (2015-2026)
2.8.2 Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Human Vaccines Market Assessment by Segment
3.1 Global Human Vaccines Capacity and Growth Rate
3.2 Global Human Vaccines Sales by Type
3.3 Global Human Vaccines Sales Revenue by Type
3.4 Global Human Vaccines Consumption by Application
4 Global Human Vaccines Market Assessment by Regions
4.1 Global Human Vaccines Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Human Vaccines Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Human Vaccines Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Human Vaccines Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Human Vaccines Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Human Vaccines Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Human Vaccines Sales Market Share of Manufacturers (2019-2020)
6.3 Global Human Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
7 Human Vaccines Competitive Analysis
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Profiles
7.1.2 AstraZeneca plc Product Introduction
7.1.3 AstraZeneca plc Human Vaccines Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Bavarian Nordic
7.2.1 Bavarian Nordic Company Profiles
7.2.2 Bavarian Nordic Product Introduction
7.2.3 Bavarian Nordic Human Vaccines Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bharat Biotech
7.3.1 Bharat Biotech Company Profiles
7.3.2 Bharat Biotech Product Introduction
7.3.3 Bharat Biotech Human Vaccines Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 CSL Limited
7.4.1 CSL Limited Company Profiles
7.4.2 CSL Limited Product Introduction
7.4.3 CSL Limited Human Vaccines Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Emergent BioSolutions, Inc.
7.5.1 Emergent BioSolutions, Inc. Company Profiles
7.5.2 Emergent BioSolutions, Inc. Product Introduction
7.5.3 Emergent BioSolutions, Inc. Human Vaccines Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Profiles
7.6.2 GlaxoSmithKline plc Product Introduction
7.6.3 GlaxoSmithKline plc Human Vaccines Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Profiles
7.7.2 Johnson & Johnson Product Introduction
7.7.3 Johnson & Johnson Human Vaccines Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Merck & Co, Inc.
7.8.1 Merck & Co, Inc. Company Profiles
7.8.2 Merck & Co, Inc. Product Introduction
7.8.3 Merck & Co, Inc. Human Vaccines Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Mymetics
7.9.1 Mymetics Company Profiles
7.9.2 Mymetics Product Introduction
7.9.3 Mymetics Human Vaccines Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Novartis AG
7.10.1 Novartis AG Company Profiles
7.10.2 Novartis AG Product Introduction
7.10.3 Novartis AG Human Vaccines Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Pfizer, Inc.
7.12 Sanofi S.A.
7.13 Shenzhen Kangtai Biological Products Co., Ltd.
7.14 Takeda Pharmaceutical Company Limited
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
